Failure of high-dose insulin treatment to increase β-cell insulin content in diabetic non obese diabetic (NOD) mice

Diabetes Research and Clinical Practice

Volumn 37, Issue 1, 1997, Pages 9-14

  Bache, Iben ^a   Jørgensen, Klavs H ^a   Buschard, Karsten ^a  

^a Center for Health and Society   (Denmark)

Author keywords

cells; IDDM; Insulin; NOD mice

Indexed keywords

INSULIN; ISOPHANE INSULIN; NEUTRAL INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN, ISOPHANE; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD;

EID: 0030747586     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00056-9     Document Type: Article

References (13)

1. C.F. Gotfredsen, K. Buschard, E.K. Frandsen, Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals, Diabetologia 28 (1985) 933-935.
2. M.A. Atkinson, N.K. Maclaren, R. Luchetta, Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy, Diabetes 39 (1990) 933-937.
3. R.J. Keller, G.S. Eisenbarth, R.A. Jackson, Insulin prophylaxis in individuals at high risk of type 1 diabetes, Lancet 341 (1993) 927-928.
4. S.C. Shah, J.I. Malone, N.E. Simpson, A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus, N. Engl. J. Med. 320 (1989) 550-554.
5. G.L. King, C.R. Kahn, M.M. Rechler, S.P. Nissley, Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor, J. Clin. Invest. 66 (1980) 130-140.
6. A. Rabinovitch, C. Quigley, T. Russell, Y. Patel, D.H. Mintz, Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet β-cell replication in neonatal rat pancreatic monolayer cultures, Diabetes 31 (1982) 160-164.
7. D.K. McCulloch, D.J. Koerker, S.E. Kahn, S. Bonner-Weir, J.P. Palmer, Correlations of in vivo β-cell function tests with β-cell mass and pancreatic insulin content in streptozotocin-administered baboons, Diabetes 40 (1991) 673-679.
8. L. Thim, M.T. Hansen, K. Norris, et al., Secretion and processing of insulin precursors in yeast, Proc. Natl. Acad. Sci. USA 83 (1986) 6766-6770.
9. L.G. Heding, Determination of total serum insulin (IRI) in insulin-treated diabetic patients, Diabetologia 8 (1972) 260-266.
10. J. Schlichtkrull, J. Brange, Aa.H. Christiansen, et al., Monocomponent insulin and its clinical implications, Horm. Metab. Res. (Suppl. Ser.) 5 (1974) 134-143.
11. Y.T. Kruszynska, L. Villa-Komaroff, P.A. Halban, Islet β-cell dysfunction and the time course of recovery following chronic overinsulinisation of normal rats, Diabetologia 31 (1988) 621-626.
12. S. Madsbad, T. Krarup, O.K. Faber, C. Binder, L. Regeur, The transient effect of strict glycaemic control on B cell function in newly diagnosed Type 1 (insulin-dependent) diabetic patients, Diabetologia 22 (1982) 16-20.
13. K. Perlman, R.M. Ehrlich, R.M. Filler, A.M. Albisser, Sustained normoglycemia in newly diagnosed type 1 diabetic subjects. Short-term effects and 1-year follow-up, Diabetes 33 (1984) 995-1001.